◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

MediPharm Labs Corp.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item FY 2024Dec 31, 2024 FY 2023Dec 31, 2023 FY 2022Dec 31, 2022 FY 2021Dec 31, 2021
Total Revenue 42.0M 33.1M 22.1M 21.7M
Operating Revenue 45.2M 36.8M 25.0M 21.7M
Cost Of Revenue 29.2M 27.2M 24.0M 37.0M
Gross Profit 12.8M 5.9M -1.9M -15.2M
Selling General And Administration 22.9M 24.8M 24.8M 23.0M
General And Administrative Expense 19.8M 21.6M 22.1M 18.4M
Research And Development 235,000 209,000 1.0M 1.4M
Depreciation And Amortization In Income Statement 431,000 453,000 831,000 1.4M
Other Operating Expenses -66,000 66,000 146,000 -4.8M
Operating Expense 23.4M 23.6M 26.9M 27.8M
Operating Income -10.6M -17.7M -28.8M -43.0M
EBIT -10.1M -13.0M -30.0M -44.2M
Interest Expense 576,000 365,000 31,000 10.5M
Interest Expense Non Operating 576,000 365,000 31,000 10.5M
Interest Income 691,000 840,000 479,000 225,000
Interest Income Non Operating 691,000 840,000 479,000 225,000
Net Interest Income 115,000 475,000 448,000 -10.3M
Other Income Expense -241,000 3.9M -1.7M -1.4M
Special Income Charges -296,000 4.4M -913,000 -4.2M
Restructuring And Mergern Acquisition 0.00 -4.7M 0.00 --
Write Off 0.00 40,000 0.00 --
Gain On Sale Of Security 55,000 -456,000 -740,000 2.8M
Pretax Income -10.7M -13.4M -30.0M -54.7M
Tax Provision 0.00 -276,000 -6,000 113,000
Tax Effect Of Unusual Items 0.00 80,843 -330.72 -370,470
Net Income From Continuing And Discontinued Operation -10.7M -13.1M -30.0M -54.8M
Net Income From Continuing Operation Net Minority Interest -10.7M -13.1M -30.0M -54.8M
Net Income Including Noncontrolling Interests -10.7M -13.1M -30.0M -54.8M
Minority Interests -- -- -- 0.00
Net Income Common Stockholders -10.7M -13.1M -30.0M -54.8M
Net Income -10.7M -13.1M -30.0M -54.8M
EBITDA -7.5M -10.5M -27.1M -38.5M
Normalized EBITDA -7.3M -14.4M -25.4M -37.2M
Reconciled Depreciation 2.6M 2.5M 2.9M 5.6M
Basic EPS -0.03 -0.04 -0.11 -0.22
Diluted EPS -0.03 -0.04 -0.11 -0.22
Basic Average Shares 408.0M 363.3M 276.9M 249.9M
Diluted Average Shares 408.0M 363.3M 276.9M 249.9M
Total Unusual Items -241,000 3.9M -1.7M -1.4M
Total Unusual Items Excluding Goodwill -241,000 3.9M -1.7M -1.4M
Tax Rate For Calcs 0.00 0.02 0.00 0.27
Normalized Income -10.5M -16.9M -28.3M -53.8M
Depreciation Amortization Depletion Income Statement 431,000 453,000 831,000 1.4M
Depreciation Income Statement 431,000 453,000 831,000 1.4M
Diluted NI Availto Com Stockholders -10.7M -13.1M -30.0M -54.8M
Excise Taxes 3.2M 3.8M 2.9M --
Gain On Sale Of Business 0.00 -251,000 -906,000 0.00
Gain On Sale Of Ppe -296,000 174,000 -7,000 --
Impairment Of Capital Assets 0.00 183,000 0.00 4.2M
Insurance And Claims 391,000 959,000 1.4M --
Net Income Continuous Operations -10.7M -13.1M -30.0M -54.8M
Net Non Operating Interest Income Expense 115,000 475,000 448,000 -10.3M
Other Gand A 6.6M 6.1M 6.7M 7.4M
Provision For Doubtful Accounts -83,000 -1.9M 134,000 6.8M
Reconciled Cost Of Revenue 27.0M 25.1M 22.0M 32.7M
Rent And Landing Fees 608,000 582,000 242,000 366,000
Rent Expense Supplemental 1.3M 1.3M 586,000 366,000
Salaries And Wages 12.3M 14.0M 13.8M 10.6M
Selling And Marketing Expense 3.0M 3.2M 2.6M 4.6M
Total Expenses 52.5M 50.8M 50.9M 64.7M
Total Operating Income As Reported -10.8M -18.3M -29.5M -48.9M
Line Item FY 2024Dec 31, 2024 FY 2023Dec 31, 2023 FY 2022Dec 31, 2022 FY 2021Dec 31, 2021
Cash And Cash Equivalents 11.7M 18.0M 24.1M 34.1M
Cash Cash Equivalents And Short Term Investments 11.7M 18.0M 24.1M 34.1M
Cash Equivalents -- -- 229,000 226,000
Cash Financial -- -- 23.9M 33.9M
Accounts Receivable 6.9M 5.5M 12.3M 15.3M
Receivables 7.5M 5.9M 13.0M 16.9M
Inventory 8.7M 9.9M 7.8M 11.0M
Prepaid Assets 609,000 900,000 1.4M 2.2M
Other Current Assets 213,000 194,000 146,000 433,000
Current Assets 33.1M 36.6M 47.3M 65.5M
Gross PPE 42.5M 52.3M 43.2M 51.3M
Accumulated Depreciation -23.3M -27.0M -25.0M -25.4M
Net PPE 19.2M 25.3M 18.1M 25.9M
Goodwill And Other Intangible Assets 854,000 1.0M 39,000 44,000
Other Intangible Assets 854,000 1.0M 39,000 44,000
Investments And Advances -- -- -- 0.00
Total Non Current Assets 20.6M 27.3M 18.1M 26.8M
Total Assets 53.7M 63.9M 65.5M 92.4M
Current Debt 258,000 2.1M 523,000 --
Current Debt And Capital Lease Obligation 337,000 2.2M 598,000 113,000
Accounts Payable 4.2M 2.1M 3.5M 3.0M
Payables 5.1M 2.5M 3.9M 3.3M
Payables And Accrued Expenses 6.8M 4.9M 5.8M 4.9M
Current Accrued Expenses 1.7M 2.4M 1.9M 1.6M
Current Deferred Revenue 607,000 391,000 492,000 1.3M
Other Current Liabilities -- 829,000 829,000 --
Current Liabilities 10.5M 10.9M 9.5M 8.9M
Long Term Debt And Capital Lease Obligation 51,000 69,000 34,000 103,000
Long Term Capital Lease Obligation 51,000 69,000 34,000 103,000
Total Non Current Liabilities Net Minority Interest 51,000 69,000 34,000 338,000
Total Liabilities Net Minority Interest 10.5M 10.9M 9.5M 9.2M
Common Stock 201.2M 200.2M 191.3M 190.6M
Capital Stock 201.2M 200.2M 191.3M 190.6M
Retained Earnings -187.4M -176.7M -163.6M -129.3M
Gains Losses Not Affecting Retained Earnings 29.4M 29.5M 28.4M 21.9M
Other Equity Adjustments 29.4M 29.5M 28.4M 21.9M
Common Stock Equity 43.2M 53.0M 56.0M 83.1M
Stockholders Equity 43.2M 53.0M 56.0M 83.1M
Total Equity Gross Minority Interest 43.2M 53.0M 56.0M 83.1M
Total Capitalization 43.2M 53.0M 56.0M 83.1M
Net Tangible Assets 42.3M 52.0M 56.0M 83.1M
Tangible Book Value 42.3M 52.0M 56.0M 83.1M
Working Capital 22.6M 25.8M 37.9M 56.7M
Invested Capital 43.4M 55.1M 56.5M 83.1M
Total Debt 388,000 2.3M 632,000 216,000
Share Issued 415.0M 401.4M 282.2M 273.5M
Ordinary Shares Number 415.0M 401.4M 282.2M 273.5M
Allowance For Doubtful Accounts Receivable -78,000 -208,000 -6.2M --
Assets Held For Sale Current 4.3M 1.8M 829,000 910,000
Buildings And Improvements 25.3M 28.2M 21.1M 25.5M
Capital Lease Obligations 130,000 190,000 109,000 216,000
Construction In Progress 45,000 2.5M 2.6M 4.5M
Current Capital Lease Obligation 79,000 121,000 75,000 113,000
Current Deferred Liabilities 607,000 391,000 492,000 1.3M
Derivative Product Liabilities -- -- 0.00 2,000
Dueto Related Parties Current -- -- -- 0.00
Dueto Related Parties Non Current -- -- -- 0.00
Finished Goods 5.9M 6.4M 5.5M 8.2M
Gross Accounts Receivable 7.0M 5.7M 18.6M --
Investmentin Financial Assets -- -- -- 0.00
Land And Improvements 1.9M 2.9M 1.6M 2.0M
Leases 209,000 209,000 209,000 209,000
Machinery Furniture Equipment 14.4M 17.5M 16.7M 18.2M
Non Current Accounts Receivable -- -- -- 123,000
Non Current Deferred Liabilities -- -- 0.00 233,000
Non Current Deferred Revenue -- -- 0.00 233,000
Non Current Prepaid Assets 635,000 1.0M 0.00 753,000
Other Current Borrowings 258,000 2.1M 523,000 --
Other Inventories 147,000 12,000 -- --
Other Payable 826,000 382,000 324,000 307,000
Other Properties 738,000 905,000 905,000 910,000
Other Receivables 32,000 79,000 501,000 1.5M
Pensionand Other Post Retirement Benefit Plans Current 2.8M 2.5M 1.7M 2.5M
Properties 0.00 0.00 0.00 0.00
Raw Materials 2.6M 3.5M 2.2M 2.8M
Taxes Receivable 602,000 272,000 159,000 120,000
Tradeand Other Payables Non Current -- -- -- 0.00
Line Item FY 2024Dec 31, 2024 FY 2023Dec 31, 2023 FY 2022Dec 31, 2022 FY 2021Dec 31, 2021
Operating Cash Flow -4.9M -12.3M -16.1M -13.2M
Cash Flow From Continuing Operating Activities -4.9M -12.3M -16.1M -13.2M
Depreciation And Amortization 2.6M 2.5M 2.9M 5.6M
Depreciation Amortization Depletion 2.6M 2.5M 2.9M 5.6M
Stock Based Compensation 976,000 2.0M 2.9M 2.4M
Deferred Tax -- -- -6,000 113,000
Deferred Income Tax -- -- -6,000 113,000
Change In Working Capital 1.7M 3.5M 6.2M 6.4M
Changes In Account Receivables -1.6M 6.3M 3.6M 5.9M
Change In Receivables -1.6M 6.4M 3.6M 10.2M
Change In Inventory 663,000 3.3M -103,000 2.5M
Change In Payables And Accrued Expense 1.9M -5.2M 1.5M -8.1M
Change In Payable 1.9M -5.2M 1.5M -8.1M
Change In Other Working Capital 413,000 150,000 -- --
Change In Other Current Assets 272,000 -1.2M 1.8M 696,000
Change In Other Current Liabilities -- 150,000 -515,000 1.1M
Other Non Cash Items 569,000 -7.3M -483,000 10.3M
Capital Expenditure -154,000 -471,000 -863,000 -783,000
Net PPE Purchase And Sale 347,000 178,000 0.00 311,000
Sale Of Business 0.00 5.3M 6.0M 0.00
Purchase Of Investment -- -- -- 0.00
Net Investment Purchase And Sale -- -- -- 0.00
Investing Cash Flow 413,000 6.9M 5.2M 35,000
Cash Flow From Continuing Investing Activities 413,000 6.9M 5.2M 35,000
Issuance Of Debt 799,000 1.1M 1.3M 0.00
Repayment Of Debt -3.1M -2.0M -948,000 -3.0M
Net Issuance Payments Of Debt -2.3M -944,000 393,000 -3.0M
Issuance Of Capital Stock -- -- 0.00 30.9M
Net Common Stock Issuance -- -- 0.00 30.9M
Financing Cash Flow -1.8M -368,000 796,000 27.8M
Cash Flow From Continuing Financing Activities -1.8M -368,000 796,000 27.8M
Effect Of Exchange Rate Changes 4,000 -329,000 150,000 -429,000
Changes In Cash -6.3M -5.8M -10.1M 14.6M
Beginning Cash Position 18.0M 24.1M 34.1M 19.9M
End Cash Position 11.7M 18.0M 24.1M 34.1M
Free Cash Flow -5.0M -12.8M -16.9M -14.0M
Amortization Cash Flow 178,000 112,000 5,000 --
Amortization Of Intangibles 178,000 112,000 5,000 --
Asset Impairment Charge 466,000 1.7M 1.4M 12.9M
Capital Expenditure Reported -154,000 -471,000 -863,000 -783,000
Cash Dividends Paid 0.00 0.00 0.00 0.00
Common Stock Issuance -- -- 0.00 30.9M
Depreciation 2.4M 2.4M 2.9M --
Gain Loss On Investment Securities -- -- -2,000 -4.5M
Gain Loss On Sale Of Business 0.00 251,000 906,000 0.00
Gain Loss On Sale Of PPE -296,000 -173,000 7,000 -6,000
Interest Paid Cff -300,000 -264,000 -26,000 -12,000
Long Term Debt Issuance 799,000 1.1M 1.3M 0.00
Long Term Debt Payments -136,000 -248,000 -130,000 -3.0M
Net Business Purchase And Sale 0.00 5.3M 6.0M 0.00
Net Foreign Currency Exchange Gain Loss -51,000 191,000 0.00 1.7M
Net Income From Continuing Operations -10.7M -13.1M -30.0M -54.8M
Net Long Term Debt Issuance 663,000 818,000 -130,000 -3.0M
Net Other Financing Charges 691,000 840,000 429,000 -139,000
Net Other Investing Changes 220,000 1.9M 7,000 507,000
Net Short Term Debt Issuance -2.9M -1.8M 523,000 --
Operating Gains Losses -347,000 269,000 911,000 -2.9M
Proceeds From Stock Option Exercised 14,000 0.00 -- 0.00
Provisionand Write Offof Assets -83,000 -1.9M 134,000 6.8M
Sale Of PPE 347,000 178,000 0.00 311,000
Short Term Debt Issuance -- 1.1M 1.3M --
Short Term Debt Payments -2.9M -1.8M -818,000 --
NEWS
Loading news...
TRENDING
Loading...